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Fertility preservation in the cancer setting, knownas oncofertility, is a field that requires cross-disciplinary
interaction between physicians, basic scientists, clinical researchers, ethicists, lawyers, educators, and
religious leaders. Funded by the National Institutes of Health, the Oncofertility Consortium (OC) was formed
to be a scientifically grounded, transparent, and altruistic resource, both intellectual and monetary, for
building this new field of practice capable of addressing the unique needs of young patients with cancer.
The OC has expanded its attention to include other nonmalignant conditions that can threaten fertility, and
theworkof theOCnowextendsaround theglobe, involvingpartnerswho togetherhavecreatedacommunity
of shared effort, resources, and practices. The OC creates materials that are translated, disseminated, and
amended by all participants in the field, and local programs of excellence have developed worldwide to
accelerate the pace and improve the quality of oncofertility research and practice. Here we review the
global oncofertility programs and the capacity building activities that strengthen these research and
clinical programs, ultimately improving patient care.
INTRODUCTION
Survival rates among young patients with cancer
have steadily increased over the past three de-
cades, in part because of the development of
more effective cancer treatments.1,2 Today, both
women and men can look forward to life after
cancer; however,manymay face thepossibility of
infertility as a result of the disease itself or these
lifesaving treatments. Established in 2007 as part
of a National Institutes of Health center grant, the
Oncofertility Consortium (OC) is an interinstitu-
tional, interdisciplinary consortium to expand re-
search in fertility loss in patients with cancer,
accelerate clinical translation of fertility preser-
vation techniques, and address the complex
health care andquality-of-life issues that concern
young patients with cancer whose fertility may be
threatened by their disease or its treatment.3-7
The term oncofertility was originally coined to
describe a new discipline that bridges oncology
and reproductive medicine to discover and apply
new fertility preservation options for young pa-
tients with cancer. However, as the OC worked
to create fertility preservation technologies and
clinical oncology management plans for patients
with cancer, it became clear that fertility con-
cerns resulting from nonmalignant diseases
and iatrogenic causes were much broader
than just those associated with cancer. GI dis-
eases, rheumatologic disorders, nonmalignant
hematologic conditions (most prominently
b thalassemia), neurologic disorders, renal
disorders, gynecologic conditions, and meta-
bolic diseases can all adversely affect fertility.
By expanding its scope, the OC now ensures
that all patients facing a disease or treatment
that limits reproductive function can benefit
from the findings of basic and clinical repro-
ductive research. The word oncofertility was
created when few options were available and
now provides terminology for a medical field at
the intersection of many iatrogenic causes of
infertility.
To facilitate sharing of knowledge and re-
sources, the OC formed the National Physicians
Cooperative, which today represents . 60 cen-
ters across the United States that provide onco-
fertility services to men and women, as well as
19 centers focused on pediatric patients.8 Since
its inception, the OC has aimed to involve more
partners to create a nationwide community of
shared resources and practices, with the ulti-
mate goal of improving patient care. Today,
there is wide acceptance that partnerships that
bring research and clinical teams together cat-
alyze progress, and the global partnerships dis-
cussed here aremoving quickly to provide broad
reproductive care to anyone experiencing an
iatrogenic impact on reproduction, fertility, or
sexuality.2
There are currently 19 countries engaged in the
global oncofertility community (Fig 1), and the
hope is to continue to grow and expand these
relationships. As individual centers of excellence
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realize the intrinsic value in joining a larger global
community of shared practices, the global onco-
fertility community is strengthened, and the OC
and its partners can begin to engage international
advocacy groups, governments, and others. Ad-
vances in technology, suchas videoconferencing,
connect researchers, scientists, and patients from
around the globe, making real-time sharing of
scientific results and medical best practices pos-
sible and raising awareness among diverse
stakeholders. By breaking free of the outdated,
reclusive nature of the scientific community, and
being willing to share successes, failures, chal-
lenges, and triumphs, the OC is building the field
of oncofertility, from bench to bedside to babies.
Engaging all stakeholders, beyond scientists and
clinicians, will continue to broaden the influ-
ence of the community and improve care for all
patients.
Global partners of the OC receive tools and guid-
ance to set up their own local consortia (Fig 2).
The administrative core of the OC at Northwest-
ern University serves global partners in its efforts
to build and expand its existing services and
outreach. All of the OC materials on the main
website (oncofertility.northwestern.edu) and
other online resources are made available to
global partners, including the iSaveFertility mobile
app (savemyfertility.org), patient navigator tools
(preservefertility.northwestern.edu), decision
aids (myoncofertility.org), and Repropedia
(http://www.repropedia.org), an online reproduc-
tive lexicon. Branding materials are available at
oncofertility.northwestern.edu/branding-materials.
Global partners are encouraged to translate these
materials and disseminate them to international
audiences, while in turn providing our team with
new content and links to include on the main OC
Web site (oncofertility.northwestern.edu). A com-
plete list of active global partners and the work
they have contributed can be found here: http://
oncofertility.northwestern.edu/global-oncofertility-
partners. Making these materials available to all
partners fosters interaction and a shared language
and purpose among diverse groups, which en-
ables our global partners to apply these resources,
methodologies, and other experiences in the field.
Guidelines are not within the scope of the consor-
tium,but theOCdoesprovidea site for aggregation
and dissemination of guidelines from formal med-
ical societies, and guidelines for our field from
oncology, fertility, pediatric, and nursing spe-
cialty groups from around the globe can be
found in one central location (http://oncofertility.
northwestern.edu/ODT-web-portal). Establishing a
strong global network not only drives the collab-
orative nature of the OC, but also helps global
partners build their own consortia and fertility
preservation networks.9
As part of the global partnersmodel (Fig 3), theOC
works with multidisciplinary reproductive special-
ists from all over the world in an effort to better
servechildren, adolescents, andyoungadultswith
cancer and other fertility-threatening diseases.
Global collaborations shed new light on fertility-
threatening conditions in other countries, reveal
new perspectives on addressing broad cultural
issues, and increase the reach of cutting-edge
scientific discoveries. It is this interdisciplinary,
multicultural, and multilingual dialogue that the
OC thrives on to continue to advance scientific
research and translate discovery to outstanding
clinical care around the globe.
CASE FOR GLOBAL NETWORKING TO ESTABLISH
REPRODUCTIVE HEALTH STANDARDS OF CARE
In recent decades, globalization has extended the
reach of research universities,10 with striking suc-
cess in advancing knowledge.11 Similarly, extend-
ing theoncofertility networkbeyond theconfinesof
the United States and into the international realm
not only advances knowledge and promotes dis-
covery, but also provides uniform access for all
experts and their unique perspectives. These col-
laborations benefit the scientific community by
accelerating the pace of discovery and decreasing
the time to clinical application. The capacity for
making landmark breakthroughs in the field is
enhanced. Furthermore, research has shown that
the trend toward international collaboration and
network building attracts attention to issues and
leads to a greater number of publications and
greater support for basic research and clinical
studies.12Global partnerships, including research
collaborations and joint authorships, strengthen
thedisseminationof scientific results; as the size of
the audience increases, so does the reach and
influence of the research, thus increasing the
potential translational impact the research may
have on future patient care.
Because of the intrinsic value in creating diverse
networks and collaborations, the OC continues its
efforts to connect local centers of excellence and
create a strong global network of diverse collabo-
rators, many of whom may not have worked to-
gether otherwise. The OC supports interaction
between global and local partners to create mo-
mentum for clinical activities (shared protocols
and patient case studies, inclusion of allied health
professionals), research (sharing results, both
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failures and successes, in ways that hasten work),
andmeeting patient needs (educational Web sites,
patient decision tools, patient navigator). By facil-
itating these interactions, the OC ensures the
coordinated effort of the global oncofertility com-
munity in conducting cutting-edge research that
can continue to be rapidly translated to the
clinic and establish an evidence-based standard
of care.
Today, many global partners are contributing to
the worldwide oncofertility network (Table 1).
Here, we describe six partners that have been
actively engaged with the OC and have made
notable contributions to the field, with programs
that areuniquely tailored to theneedsof patients in
their respective countries. The OC provided the
basic foundation, insights, and resources for
establishing these centers, which serve to extend
fertility preservation research efforts; in return,
these global partners share their diverse perspec-
tives, experiences, scientific findings, and atti-
tudes with the OC and other global partners to
enrich patient care.
Australasia
In Australia andNewZealand, a number of cancer
and fertility groups have developed specific onco-
fertility services and are undertaking research
studies to bridge the intellectual, disciplinary,
and logistic gaps between reproductive medicine
and oncology. The Fertility Society of Australia
established a special interest group in 2008 with
the aim of facilitating collaborative research and
improving communication and education be-
tween cancer and fertility clinicians.
TheAustralasianOCwas established in 2014 and is
committed to interdisciplinary innovation. The con-
sortium endeavors to support the collaborative ef-
forts of cancer and fertility clinicians in Australasia
(Australia andNewZealand) to improve oncofertility
practice and services. The consortium developed
theAustralasianOncofertilityCharter,whichoutlines
thegold-standardmodel for care tobe implemented
at each service. Working closely with consumer
groups, . 30 resources on the topics of fertility
preservation, sexual health, and sexual dysfunction
have been made available on our Web site (http://
www.futurefertility.com.au). They are currently in
the process of developing e-learning tools that will
also be available for clinicians early in the new year.
The FUTuRE (Fertility Understanding Through
Registry and Evaluation) Fertility Team is a bi-
national group of researchers who set up the
Australasian Oncofertility Registry using a Web-
based platform. In 2015, this registry will start
collecting oncofertility population data from pa-
tients with cancer in Australia and New Zealand
ages 0 to 45 years. These data will reveal referral
patterns for fertility preservation, uptake, and use
of fertility preservation, reproductive risk based on
annual follow-up of patients, and pregnancy out-
comes (both natural and assisted in patients with
cancer). This will be the first population-based na-
tional oncofertility registryandwill produce invaluable
Implementation PhaseInitiation Phase
Global center
contacts
oncofertility
consortium to
inquire about
global
partnership
Administrative
core at the OC
initiates video
conference to
introduce the
center and
discuss
membership
Team assesses
needs of the
global center and
guides them
through all of the
available online
tools, guidelines,
and branding
materials
OC provides global
partner with center
specific guidance
and develops a
webpage together:
     oncofertility.
northwestern.edu/
global-oncofertility-
partners
Global partners are
encouraged to translate
any and all materials to
their native language.
This includes:
• iSaveFertility mobile app
•  The myoncofertility
website for patients,
parents and partners.
• Any of the materials
on the main website.
• Branding materials are
  also available to all 
  global partners.
The OC invites global
partners to participate
in survey studies,
attend the annual
conference, submit
poster abstracts and
give a presentation
at the annual Global
Partners’ Breakfast to
discuss best practices
and challenges in an
open forum
Figure 1 –
Map of countries (purple)
represented in Oncofertility
Consortium global partners
network.
Figure 2 –
Flow chart: becoming
global partner. OC,
Oncofertility Consortium.
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insights into oncofertility care that are highly rele-
vant to the efforts of international colleagues.
Brazil
The Brazilian OC (BOC) was officially created
in 2012. Known nationally in Brazil as Rede Bra-
sileira de Oncofertilidade and coordinated by
Jhenifer K.Rodrigues, PhD, the group is a network
of professional members who share experiences,
materials, research protocols, and ideas and en-
gage in collaborative research projects. The net-
work includes the Pro´-CriarMedicinaReprodutiva
and Human Reproduction Laboratory/Federal
University of Minas Gerais from the state of Minas
Gerais (southeast), Huntington Medicina Repro-
dutiva and Medical School of Ribeir~ao Preto/
University of S~ao Paulo from S~ao Paulo state
(southeast), Fertilitat Centro de Medicina Repro-
dutiva from Rio Grande do Sul (south), Laboratory
of Oocytes and Preantral Follicles Manipulation/
State University of Ceara´ from Ceara´ (north),
Geˆnesis Centro de Assisteˆncia em Reproduç~ao
Humana (Brası´lia, Federal District; central east-
ern), and Cenafert Centro de Medicina Repro-
dutiva from the state of Bahia (northeast; Fig 4).
The BOC has increased the level of aware-
ness and national discussion about the fertility
preservation options of patients with cancer.
Through the BOC, patients with cancer are di-
rected to key centers of assisted reproduction,
which offer themost advanced research protocols
for cryopreservation of semen, oocytes, embryos,
andovarian tissue topreserve fertility.Patientsalso
receive psychological treatment to aid in the
decision-making process.
In Fortaleza, the group was founded in 2014. It
offers new therapy in the region for the treatment of
cancer and its morbidities, with preservation of
tissue function through ovarian tissue cryopreser-
vation. In addition, there is a group developing
notable research on ovarian tissue reimplantation
using animal models and evaluating the effect of
autograft in restoration of bone metabolism.
In just 2 years, the BOC has formed connections
with other global oncofertility groups, including the
Korean Society for Fertility Preservation (KSFP)
and the Japan Society for Fertility Preservation
(JSFP). The BOC has also collaborated on publi-
cations and research projects with the OC in the
United States. The group has already published a
native-language oncofertility book with contribu-
tions from experts across Brazil and some from
abroad. Now the group is working on developing
more native-language resources to further con-
nect with patients in Brazil. Efforts in Brazil are
beingmade to bridge the gapbetween oncologists
and reproductive specialists to help inform pa-
tients with cancer about their fertility preservation
options and reproductive future.
Oncofertility Consortium Global Partnerships
Interdisciplinary, multicultural, and multi-
lingual dialogue produces cutting-edge 
scientific research, which translates to 
outstanding clinical care across the globe.
Global partners build and expand their
existing services and outreach.
Expanding collaborations outside
traditional institutional boundaries
brings a variety of perspectives to
research and patient care.
Global collaborations shed new light on 
fertility threatening conditions that may be 
geographically restrictive, provide 
perspective on dealing with broad cultural 
issues, and increase the reach of 
cutting-edge scientific discovery.
Coordinated Community
of Practice
Multifaceted
approaches
connect cultures,
communities,
and countries
with a global
mission.
Researchers
Clinicians
Ethical &
  cultural matters
Language
barriers
Literature
Family
Patient
Partners
Figure 3 –
Oncofertility Consortium
global partnerships model.
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Table 1 – Global Partner Institutions and Notable Accomplishments
Name Notable Accomplishments
Australia
Robinson Research Institute, University of
Adelaide
Comprises 40 research leaders and some 350 members focused on research in
reproduction, pregnancy, and children’s health
Members are active participants in Australasian Oncofertility Registry
Scientists and clinicians are focused on advancing technologies that enable
development of successful fertility treatments for women and men with cancer
FUTuRE Fertility Research Group, Randwick Set up Australasian Oncofertility Registry
Developed patient resources and national Web sites (eg, http://www.futurefertility.
com.au)
Launched Australasian Oncofertility Charter and developed number of national
oncofertility research studies
Belgium
Centrum voor Reproductieve Geneeskunde,
Universitair Ziekenhuis Brussel
Longstanding record of pioneering reproductive treatment, including
intracytoplasmic sperm injection as fertilization technique for couples with male
factor infertility
Since late 1990s, has conducted translational research to connect advances in
follicle biology with those in assisted reproductive technology
Develops and applies patient-tailored fertility preservation methods, including
combination of ovarian cortex cryopreservation, in vitro maturation of oocytes
harvested transvaginally or ex vivo, and random-onset ovarian stimulation
Established spermatogonial stem-cell banking program for prepubertal male
patients with cancer
Brazil
Belo Horizonte
Brazilian Oncofertility Consortium/Rede
Brasileira de Oncofertilidade, Pro´-Criar Medicina
Reprodutiva
Since 2012, has connected eight fertility preservation centers throughout Brazil
Translated entire OC Web site and published native-language oncofertility book
(to be released in 2015)
Established collaborative research projects with goal of optimizing techniques of
ovarian tissue cryopreservation and in vitro follicle maturation
Fortaleza
Ceara Human Tissue Bank Founded in 2014, offers new therapy in country for treatment of cancer and its
morbidities with preservation of tissue function through cryopreservation and
OTC
Ceara Blood Center In addition, there is research group developing notable research on ovarian tissue
reimplantation using animal models and evaluating effect of autograft in
restoration of bone metabolism
University Hospital–Federal University of Ceara
Canada
Canadian Oncofertility Consortium Launched by Karen Buzaglo, MD, from Clinique Ovo (Quebec) in 2014 to bridge
large geographic distances between major cities that do oncofertility work (ie,
Montreal, Ottawa, Toronto, and Vancouver)
Brings together fertility preservation database of each center to create national
database
With Canadian Fertility and Andrology Society, published Clinical Practice
Guidelines for fertility preservation in 2014
Adapted NPC ovarian tissue freezing protocol to create Canada-wide ovarian
tissue freezing project
Integrating patient navigator model in Canadian fertility clinics that provide fertility
preservation to coordinate all fertility preservation consultations and provide
ongoing communication between patient, oncologist, and fertility specialist
(continued on following page)
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Table 1 – Global Partner Institutions and Notable Accomplishments (continued)
Name Notable Accomplishments
Linked Cancer Knowledge Network in Canada to Canadian Fertility and Andrology
Society
First Canadian Oncofertility Symposium is being planned for 2015
Cancer Knowledge Network, Oncofertility Referral
Network
Launched in 2014 as first and only Canadian Oncofertility Referral Network that
links patients, physicians, and fertility clinics, ensuring time-sensitive needs are
met in providing fertility options for young patients with cancer
Created multidisciplinary dialogue between patients and their medical team about
fertility preservation options, offering current educational information and
resources alongside an efficient, online referral system to fertility specialists
Europe (including Austria, Germany, and
Switzerland)
FertiPROTEKT Network As of 2014, approximately 100 centers in network
Optimized stimulation therapies administered before cytotoxic therapies,
combination of ovarian stimulation with ovarian tissue cryopreservation, and
overnight transportation of ovarian tissue
Performed approximately 60 ovarian tissue transplantations
Established optimized network infrastructure with two centralized cryobanks for
ovarian tissue and 100 IVF centers
Performs . 1000 counseling sessions, approximately 250 ovarian stimulations,
and 500 cryopreservations of ovarian tissue per year
India
Manipal Centre for Fertility Preservation, Manipal
University
Established in 2014, offers fertility preservation to both prepubertal and adult
patients with cancer
Created excellent network of oncologists, embryologists, gynecologists, surgeons,
and pediatricians
Secured funding from Alexander von Humboldt Foundation (Germany) and Indian
Council of Medical Research to establish facility
Conducting clinical and experimental research projects on efficiency of Indian
medicinal plants in protecting gonads from oncotherapy
Organizes workshop and annual meetings in fertility preservation
Japan
Japanese Society for Fertility Preservation, St
Marianna University School of Medicine,
Miyamae-ku, Kawasaki, Kanagawa
Founded in 2012 by Nao Suzuki, MD, PhD, and modeled after OC in United
States
Created network of four oncofertility sites that work with 123 regional hospitals
throughout Japan to bring together patients and fertility specialists for fertility
preservation services
Partnership with government facilitates advertising of services throughout country
(Fig 5)
Korea
Korean Society for Fertility Preservation, Seoul
National University College of Medicine
Created in 2013 to facilitate collaboration between medical physicians and
researchers who specialize in reproductive medicine and oncology
Established national fertility preservation network with regional center hospital to
implement standards for use of fertility preservation
Developing clinical guideline for fertility preservation
Hosts annual conference and postgraduate course to further connect researchers
and clinicians in field
Portugal
Portuguese Center for Fertility Preservation
(CentrodePreservaç~aodaFertilidade),CoimbraHospital
and University Centre
Only center in Portugal that provides all available fertility preservation techniques;
receives referrals from oncologists of cancer institutions across country
(continued on following page)
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Europe
Working froman initiative in theDepartments for
Gynecological Endocrinology and Reproduc-
tive Medicine at the Universities of Heidelberg
and Bonn in Germany, the FertiPROTEKT©
network was founded in May 2006. Two years
later, the network was extended to Austria
and Switzerland to include not only universi-
ties but also private centers offering fertility
preservation.
SinceJanuary2014,approximately100centers across
Germany, Austria, and Switzerland have joined the
FertiPROTEKT network. Similar to the OC, the Ferti-
PROTEKT network seeks to improve the standard of
care for all patients by implementing standardized pro-
tocolsandmethodsofqualitycontrol.Themainachieve-
ments of thenetworkare theoptimizationof stimulation
therapies administered before cytotoxic therapies, the
combination of ovarian stimulation with ovarian tissue
cryopreservation, and the establishment of overnight
Table 1 – Global Partner Institutions and Notable Accomplishments (continued)
Name Notable Accomplishments
Since 2010, has provided reproductive monitoring and counseling to male and
female patients from every part of country
Counseled . 100 female patients and . 300 male patients; values psychological
support of patients to better support their decisions
Conducts annual follow-up with patients
Translated and adapted materials developed by OC, including iSaveFertility
application, http://www.myoncofertility.com Web site, and Repropedia
Launching native-language Web site materials for general population, patients,
and health professionals
Scotland
Edinburgh Fertility and Reproductive Endocrine
Centre, Royal Infirmary of Edinburgh
Ovarian tissue cryopreservation was first performed in young woman at center in
1993
Offers ovarian tissue autotransplantation to highly selected group of girls and
young women
Recently completed analysis of prevalence of premature ovarian insufficiency in
girls offered ovarian tissue cryopreservation over last 15 years; because its
pediatric service is based in regional children’s cancer centre, it was able to
use accurate denominator of all children with cancer over time period studied
Laboratory-based research has demonstrated that children’s ovaries contain
significant proportion of primordial follicles with abnormal morphologic features,
but these seem to be lost during adolescence
Current research focusing on in vitro growth and maturation of primordial follicles
and developing models useful for assessing follicle density in cortical biopsies
Recently established ethically approved research program to collect prepubertal
testicular tissue in selected patients with cancer at high risk of permanent
infertility as direct result of their cancer treatment13,14
United States
National Physicians Cooperative Nationwide network of centers dedicated to preserving fertility of patients
diagnosed with cancer or diseases whose progression or treatment is likely to
impair fertility
Investigates ways to mitigate effects of any disease or treatment on ovarian and
testicular function and develops physician-guided tools that will facilitate
communication and translation between basic research and clinical practice
Monthly subcommittee meetings with leaders in fields of male fertility
preservation, female fertility preservation, pediatrics, oncology, education,
advocacy, and basic science to advance research initiatives and develop
educational materials to better serve patients and their clinicians
NPC ovarian tissue cryopreservation research protocol has IRB approval at 32
NPC institutions, with patients agreeing to donate up to 20% of their ovarian
tissue to research repository for use in future research projects while
maintaining remaining 80% for their own future use
Abbreviations: IRB, institutional review board; IVF, in vitro fertilization; NPC, National Physicians Cooperative; OC, Oncofertility Consortium; OTC, ovarian tissue cryopreservation.
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transportation of ovarian tissue. Thus far, net-
work members have performed and analyzed
approximately 60 ovarian tissue transplantations.
Furthermore, an optimized network infrastruc-
ture has been established, with two centralized
cryobanks for ovarian tissue and 100 in vitro
fertilization centers, which perform . 1,000
documented counseling sessions, 250 ovarian
stimulations, and 500 cryopreservations of ovarian
tissue per year. The homepage of the FertiPRO-
TEKTnetwork (http://www.fertiprotekt.com),which
has.100,000visitorsper year, canbeaccessed in
German or English. Annual meetings involving all
participating centers guarantee consistent ther-
apy standards among the centers. The therapy
standards of the network are constantly updated
and published.15
Japan
In November 2012, the JSFP was founded as
a nonprofit corporation (http://www.j-sfp.org)
with the aim of improving both the survival
and quality of life of young patients with
cancer in Japan. As part of this effort, the
society is currently building a network for
coordinating health care providers, using the
OC as a guide, to provide accurate information
about fertility preservation to young patients with
cancer in a timely manner. The JSFP has hosted a
number of conferences aimed at attracting the
attention of all health care providers who are
concerned with fertility preservation and onco-
fertility. To date, these conferences have been
attended by approximately 280 clinicians, nurses,
pharmacists, scientists, and others.
As shown in Figure 5, the JSFP is aiming to build
a health care coordination system capable of
quickly providing information on fertility preserva-
tion to patients with cancer and their families with-
in a specific local community. In 2013, an initial
self-contained regional health care coordination
system was established by Ken-Ichiro Morishige
and Tatsuro Furui, MD, PhD, at the Gifu University
School of Medicine, called Gifu Patients, Oncolo-
gists, and Fertility Specialists, in collaboration with
the Gifu Prefectural Government (Fig 5). Since
then, similar regional health care networks have
been established inOkayama,Nagasaki, Fukuoka,
and Okinawa Prefectures, with the intention to
achieve nationwide operation.
In 2014, the JSFP used a Health and Labor
Sciences research grant to develop the Clinical
Practice Guidelines for Preservation of Fertility in
Breast Cancer Patients in Japan (research repre-
sentative, Chikako Shimizu, MD, Breast andMed-
ical Oncology Division, National Cancer Center
Hospital). The JSFP has also secured funding from
a Health and Labor Sciences research grant for
a study titled “Development of a Psychological
Support System for Fertility Preservation Aimed at
Achieving Improvements for Young Cancer Survi-
vors” (research representative, Nao Suzuki, MD,
PhD, St Marianna University School of Medicine).
The JSFP is also working to initiate a clinical study
titled “Oncofertility! Psychological Education and
Couple Enrichment (O!PEACE) Therapy: An Inter-
vention Study Protocol for a Randomized Con-
trolled Trial in Japan.” The aim of this study is to
examine whether psychotherapy can reduce con-
cerns about fertility, alleviate psychological dis-
tress, and improve communication between
Brazilian Oncofertility Consortium/Rede Brasileira de Oncofertilidade–BOC/reBOC
1
2
3
4
5
6
7
8
Pró-Criar Medicina Reprodutiva (Belo Horizonte/MG) http://www.procriar.com.br/
Huntington Medicina Reprodutiva (São Paulo/SP) http://www.huntington.com.br/
Laboratório de Reprodução Humana da Faculdade de Medicina de Ribeirão Preto/USP (Ribeirão Preto/SP) http://www.fmrp.usp.br/
Fertilitat Centro de Medicina Reprodutiva (Porto Alegre/RS) http://www.fertilitat.com.br/principal.php
Laboratório de Manipulação de Oócitos e Folículos Pré-antrais-LAMOFOPA/ Universidade Estadual do Ceará (Fortaleza/CE) 
http://lamofopa.com.br/
Gênesis Centro de Assistência em Reprodução Humana (Brasília/DF) http://www.genesis.med.br/
Laboratório de Reprodução Humana Hospital das Clínicas–Universidade Federal de Minas Gerais (Belo Horizonte/MG) 
http://www.hc.ufmg.br/reproducao_humana/
Cenafert Centro de Medicina Reprodutiva (Salvador/BA) http://www.cenafert.com.br/
Figure 4 –
Brazilian Oncofertility
Consortium.
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patients with cancer and their partners. To expand
its efforts, the JSFP is actively engaged in various
activities with OC Japan, in cooperation with the
OC, which are aimed at expanding oncofertility
programs in Asia in association with the KSFP and
the Fertility Preservation Society of India (FPI).
Portugal
ThePortugueseCentre for Fertility Preservation (at
Coimbra Hospital and University Centre) was cre-
ated in 2010 to meet the reproductive needs of
patients undergoing treatments that are possibly
fertility threatening. Although male fertility preser-
vation had been available in several public insti-
tutions since the1990s, female fertilitypreservation
options were not available in Portuguese public
practice. This center is the only one in the country
that provides all fertility preservation techniques to
both men and women.
The teamat the center includes six physicians, one
embryologist, one psychologist, and one pharma-
cist. Through a multidisciplinary approach, the
main goal is to provide reproductive monitoring
and counseling to male and female patients un-
dergoing gonadotoxic treatments. This team sup-
ports the patients’ decision-making process about
fertility preservation and supports their reproductive
decisions after treatment through regular follow-up
consultations (Fig 6).
Although most of the patients with cancer are
referred to the center by their oncologists, a signif-
icant number of them ask for a consultation on
their own. Thus, another goal of this center is to try
to better inform patients, health professionals, and
the general population about the impact of cancer
on fertility, the techniques available for fertility
preservation, and how to assemble a team that can
providepatientscounselingandassistance inmaking
decisions. To achieve this goal, the center has de-
veloped information fact sheets for patients and,
in collaboration with the Portuguese Society for
ReproductiveMedicine,hasorganizedpostgraduate
courses. Somematerials from the OC (eg, iSaveFer-
tility app, Web site http://www.myoncofertility.org,
and Repropedia tool) were translated into Portu-
guese to allow the center to better inform the general
population and health professionals about fertility
preservation, thereby aiding in the decision-making
process. The Portuguese Centre for Fertility Preser-
vation Web site is about to be launched and will
include information and tools tailored specifically to
Portuguese patients and health professionals. The
center is working with the Portuguese Society
of Reproductive Medicine to develop a network with
JSFP (Japan Society for Fertility Preservation)
Regional Cancer and Reproductive Treatments Network
]Patient
Cancer treatment
facilities
Psychologists,
nurses, counselors,
etc.
Providing care which
focuses not only on the
patient’s life but
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Psychological support
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Researchers
Medical cooperation not 
requiring patient 
intervention
Sharing of clinical
issues 
Obstetrics and gynecology facility
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Safe childbirth via
close cooperation
between obstetricians
and gynecologists
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other public Portuguese institutions that can pro-
vide fertility preservation techniques to improve
patient referral processes. Finally, research pro-
jects are also being developed to examine the
fertility preservation decision-making process,
the impact of this decision on future individual
adaptation, the effect of cancer treatments on
patients’ reproductive function, and new fertility
preservation techniques. Specifically in 2015, the
main goals of the Portuguese Centre for Fertility
Preservation are: to develop the first telemedicine
network in oncofertility so that patients and oncol-
ogists anywhere can reach out to the center team
to enroll inmultidisciplinary consultations tomake
more informed, shared, and quick decisions
about fertility preservation, to produce and dis-
seminate oncofertility decision aids specifically
to the pediatric population and to pediatricians,
and to create and implement protocols for
the cryopreservation of ovarian and testicular
tissues for prepubertal patients.
Korea
The KSFP was established in 2013 (http://www.
ksfp2013.org) to facilitate collaboration be-
tween medical physicians and researchers who
specialize in reproductive medicine and oncol-
ogy. The ultimate purpose of the society is to help
patients who are undergoing treatments that
will affect their fertility and reproductive
function. The goals of the KSFP are academic
education, networking, advocacy, discussion, and
development of standard protocols for fertility
preservation.
The KSFP holds an annual conference and
postgraduate course and has established a
national fertility preservation network. The Ko-
rean National Fertility Preservation Network is
a nationwide network of fertility preservation
centers. It has a three-tier structure: national
center hospitals, regional center hospitals in
each region, and regional hospitals (Fig 7).
The KSFP provides education and technical
support to the regional center hospitals of the
network, including lectures, hands-on work-
shops, and consultation. In turn, the regional
center hospitals support their associated re-
gional hospitals. The goals of this network are
to improve the quality of treatment and to
achieve the same level of quality in each
institution.
As a global partner of the OC, the KSFP collabo-
rates with all other global partners, sharing infor-
mation and experience. With regard to improving
oncofertility research and clinical programs inAsia,
the KSFP collaborates with the JSFP in Japan and
supports the plan to establish an Asian oncofertility
society.
PORTUGUESE CENTRE FOR FERTILITY PRESERVATION
ARRIVING TO THE CENTER
Through medical referral or 
patients’ own will
PHASES OF CLINICAL SUPPORT PROVISION TO THE PATIENTS
FERTILITY PRESERVATION 
TECHNIQUES
Sperm, oocytes, embryos, 
ovarian tissue
Medical consultation
Assessment of the reproductive function
Psychology consultation
DECISION-MAKING PROCESS
Medical consultation
Assessment of the reproductive function
Psychology consultation
ANNUAL FOLLOW-UP
Figure 6 –
Portuguese Centre for
Fertility Preservation.
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BARRIERS, CHALLENGES, AND OPPORTUNITIES
FOR COLLABORATIVE FUTURE IN ONCOFERTILITY
The nature of oncofertility—bridging repro-
ductive health and oncology, basic science
and clinical research, medical and social sci-
ence, and the academy and the public—
means that its work relies on collaboration.
The collective knowledge and experiences of
all OC partners and stakeholders, both na-
tional and international, are what drive the
success of the global oncofertility effort. There
are certainly challenges and barriers to suc-
cess that the OC has faced, which in part are
the ordinary issues of timeanddistance.However,
the common goals for the groups have
instilled a sense of unity among team mem-
bers. We learn from one another and in so
doing catalyze individual work. Country-to-
country restrictions (eg, on embryo banking or
use of gestational carrier) may limit activity in
one region, but a common understanding re-
garding what is possible in another area of the
work may provide insight and opportunities to
overcome these local barriers. Ultimately,
there is no precise formula to success. Be-
cause of a variety of factors, what works for
one center may not work for another. Our
success comes from simply engaging an in-
spired individual or group of individuals to act
Regional Hospital 
Regional Center  
Network Center  NC 
RC 
RH RH 
RC 
RH RH 
Goals
• To improve the quality of treatment
• To achieve the same level of quality in each
  institute
• Policy to support each hospital rather than
  make a referral system
National Fertility Preservation Network (KoFPNet)
• Nationwide network of FP centers
• Network center hospital - regional center hospitals – each regional
  hospital
• Educational and technical supports to regional center hospitals
  (lectures, hands-on workshops, consultation)
• Regional center hospitals: support each regional hospital
Figure 7 –
Korea National Fertility
Preservation Network.
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and our collective interest in the people with
iatrogenic fertility concerns that we serve. The
OC has made it possible for individual prac-
tices to tap into a worldwide network of knowl-
edge, experience, and discovery to improve
patient care. OC partners communicate and
work across disciplinary, institutional, and
geographic boundaries. Training the next
generation of oncofertility collaborators to under-
take this multidisciplinary, multinational ap-
proach, as well as to engage all stakeholders,
is essential to ensure continued rapid trans-
fer of sound science to quality medical
practice. With each new partner, particularly
those outside the traditional institutional
boundaries, a variety of new scientific, cul-
tural, ethical, and personal perspectives are
brought to bear on oncofertility research and
patient care. Multifaceted approaches to con-
nect cultures, communities, and countries show
the most promise for future success.16-18 By
engaging global partners in an inclusive ap-
proach to fertility preservation research and
clinical care, the OC will continue to create
cohesive and highly effective communities of
oncofertility practice.
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